Stay updated with breaking news from Kaivan khavandi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GSK PLC on Tuesday announced positive results from trials of depemokimab, an ultra-long-acting biologic that could simplify treatment options for patients with severe asthma.
LONDON (dpa-AFX) - GSK plc (GSK.L) Tuesday said its Phase 3 studies dubbed SWIFT-1 and SWIFT-2 evaluating depemokimab in people with severe asthma met primary endpoints.SWIFT-1 and SWIFT-2 trials ....
GSK's SWIFT trials show long-acting treatment reduces attacks fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.